UnitedHealth Group Incorporated $UNH Stake Raised by Mn Services Vermogensbeheer B.V.

Key Points

• Mn Services Vermogensbeheer B.V. increased its UnitedHealth stake by 1.5% in the third quarter, bringing its holdings to 268,333 shares valued at approximately $98.5 million. Institutional investors and hedge funds collectively own 87.86% of UNH.
• Analyst sentiment remains favorable, with 20 analysts rating the stock a Buy and eight assigning a Hold; the consensus rating is Moderate Buy with a $465.75 price target.
• UnitedHealth exceeded quarterly earnings and revenue expectations, while paying a $2.32 quarterly dividend. However, investors remain focused on medical costs, Medicare membership, guidance and potential litigation risk, and the stock has recently faced weakness ahead of earnings.

Mn Services Vermogensbeheer B.V. raised its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 1.5% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 268,333 shares of the healthcare conglomerate's stock after acquiring an additional 3,900 shares during the quarter. Mn Services Vermogensbeheer B.V.'s holdings in UnitedHealth Group were worth $98,500,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in UNH. Diversified Management Inc. bought a new stake in UnitedHealth Group during the third quarter worth approximately $1,844,000. Allen Mooney & Barnes Investment Advisors LLC boosted its stake in shares of UnitedHealth Group by 0.8% during the 3rd quarter. Allen Mooney & Barnes Investment Advisors LLC now owns 49,862 shares of the healthcare conglomerate's stock worth $18,303,000 after acquiring an additional 393 shares in the last quarter. Dorato Capital Management raised its position in shares of UnitedHealth Group by 33.5% during the third quarter. Dorato Capital Management now owns 2,621 shares of the healthcare conglomerate's stock worth $985,000 after purchasing an additional 657 shares during the period. Farther Finance Advisors LLC raised its holdings in UnitedHealth Group by 23.9% during the 3rd quarter. Farther Finance Advisors LLC now owns 28,807 shares of the healthcare conglomerate's stock worth $10,574,000 after buying an additional 5,552 shares during the period. Finally, CoreCap Advisors LLC increased its position in shares of UnitedHealth Group by 34.3% in the third quarter. CoreCap Advisors LLC now owns 3,614 shares of the healthcare conglomerate's stock worth $1,327,000 after acquiring an additional 923 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

Analyst Ratings Changes

UNH has been the subject of several research analyst reports. JPMorgan Chase & Co. increased their price objective on UnitedHealth Group from $466.00 to $516.00 and gave the stock an "overweight" rating in a research note on Tuesday, July 21st. BMO Capital Markets set a $512.00 price target on shares of UnitedHealth Group in a report on Tuesday, July 21st. Evercore increased their target price on shares of UnitedHealth Group from $400.00 to $480.00 and gave the stock an "outperform" rating in a research report on Tuesday, July 7th. DA Davidson set a $512.00 price target on shares of UnitedHealth Group in a research note on Tuesday, July 21st. Finally, Wall Street Zen upgraded UnitedHealth Group from a "hold" rating to a "buy" rating in a research note on Saturday, August 8th. Twenty analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $465.75.

UnitedHealth Group Trading Down 1.4%

Shares of UNH stock opened at $370.54 on Friday. The company has a market capitalization of $332.59 billion, a P/E ratio of 23.84, a P/E/G ratio of 1.41 and a beta of 0.60. The firm has a 50-day moving average price of $389.50 and a 200 day moving average price of $380.30. The company has a quick ratio of 0.78, a current ratio of 0.78 and a debt-to-equity ratio of 0.66. UnitedHealth Group Incorporated has a 12-month low of $255.96 and a 12-month high of $461.62.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share for the quarter, beating the consensus estimate of $4.94 by $1.44. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The firm had revenue of $112.03 billion during the quarter, compared to analysts' expectations of $110.81 billion. During the same quarter last year, the company posted $4.08 EPS. The company's quarterly revenue was up .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. Research analysts forecast that UnitedHealth Group Incorporated will post 19.85 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 22nd. Investors of record on Monday, September 14th were paid a dividend of $2.32 per share. This represents a $9.28 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date of this dividend was Monday, September 14th. UnitedHealth Group's dividend payout ratio is presently 59.72%.

Key Headlines Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth is expected to report third-quarter earnings of roughly $4.12–$4.15 per share on revenue of approximately $111.38 billion. Forecast earnings growth of about 41% reflects expectations for benefits from cost management and restructuring, although revenue growth may remain subdued. UnitedHealth Gears Up for Q3 Earnings
• Positive Sentiment: Analysts and investors are increasingly viewing UnitedHealth’s reduced price-to-earnings valuation as potentially attractive after a difficult period marked by elevated medical costs and pressure across parts of the business. A successful earnings recovery could support a re-rating. UnitedHealth’s P/E Has Reset
• Neutral Sentiment: A Medicare rate decision could provide greater visibility into reimbursement trends and help stabilize expectations for UnitedHealth’s Medicare Advantage operations, but the longer-term effect will depend on medical-cost performance and membership trends. Does a Medicare Rate Decision Steady UnitedHealth Group?
• Neutral Sentiment: Market attention is concentrated on Q3 metrics beyond earnings and revenue, including medical loss ratios, Medicare membership, operating costs and management’s full-year guidance. These factors are likely to determine whether the anticipated earnings rebound is sustainable. UnitedHealth Q3 Earnings Key Metrics
• Negative Sentiment: The stock has underperformed the broader market and is testing an important support level before earnings, signaling investor caution and leaving the shares vulnerable to further weakness if results or guidance disappoint. UnitedHealth Stock Testing Key Support
• Negative Sentiment: A law firm is soliciting UnitedHealth shareholders regarding potential fiduciary-duty issues involving company insiders. The announcement does not establish wrongdoing, but it adds headline and litigation risk ahead of earnings. Shareholder Fiduciary-Duty Inquiry

Insider Buying and Selling

In related news, CEO Patrick Conway sold 1,169 shares of the company's stock in a transaction on Friday, August 21st. The shares were sold at an average price of $390.00, for a total value of $455,910.00. Following the completion of the transaction, the chief executive officer directly owned 15,328 shares of the company's stock, valued at approximately $5,977,920. This represents a 7.09% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 0.19% of the company's stock.

About UnitedHealth Group

UnitedHealth Group Incorporated NYSE: UNH is a diversified health care and well-being company serving individuals, employers, health care providers and government programs. Its operations are organized primarily through UnitedHealthcare and Optum.

UnitedHealthcare provides health benefit plans and services, including employer-sponsored coverage, individual and family plans, Medicare and Medicaid offerings, and other government-supported programs. Its services include health insurance administration, pharmacy benefits and care management.

Optum provides health care services, technology and data solutions, pharmacy services, and analytics to health plans, employers, government agencies, health care providers and consumers.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.